- Home
- RDZN vs INMB Comparison
RDZN vs INMB Comparison
Compare RDZN & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDZN
- INMB
- Stock Information
- Founded
- RDZN 2015
- INMB 2015
- Country
- RDZN United States
- INMB United States
- Employees
- RDZN N/A
- INMB N/A
- Industry
- RDZN Blank Checks
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- RDZN Finance
- INMB Health Care
- Exchange
- RDZN Nasdaq
- INMB Nasdaq
- Market Cap
- RDZN 79.4M
- INMB 68.9M
- IPO Year
- RDZN N/A
- INMB 2019
- Fundamental
- Price
- RDZN $1.00
- INMB $2.31
- Analyst Decision
- RDZN Strong Buy
- INMB Buy
- Analyst Count
- RDZN 2
- INMB 4
- Target Price
- RDZN $5.00
- INMB $9.53
- AVG Volume (30 Days)
- RDZN 678.3K
- INMB 6.9M
- Earning Date
- RDZN 08-12-2025
- INMB 07-31-2025
- Dividend Yield
- RDZN N/A
- INMB N/A
- EPS Growth
- RDZN N/A
- INMB N/A
- EPS
- RDZN N/A
- INMB N/A
- Revenue
- RDZN $44,296,098.00
- INMB $50,000.00
- Revenue This Year
- RDZN $39.09
- INMB $82.14
- Revenue Next Year
- RDZN $65.61
- INMB $28,750.98
- P/E Ratio
- RDZN N/A
- INMB N/A
- Revenue Growth
- RDZN N/A
- INMB N/A
- 52 Week Low
- RDZN $0.68
- INMB $1.89
- 52 Week High
- RDZN $2.99
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- RDZN 48.19
- INMB 26.84
- Support Level
- RDZN $0.98
- INMB $2.22
- Resistance Level
- RDZN $1.07
- INMB $2.49
- Average True Range (ATR)
- RDZN 0.09
- INMB 0.94
- MACD
- RDZN -0.00
- INMB -0.24
- Stochastic Oscillator
- RDZN 26.67
- INMB 4.31
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.